Experiments with cold exposure confirmed previous studies indicating that the endogenous protein activator of phosphodiesterase (PDEA) isolated by Cheung participates in the in vivo regulation of 3':5'-cyclic adenosine monophosphate (cAMP) indicates that the PDEA does not contain radioactive phosphate in its structure. Also, PDEA could not be phosphorylated by protein kinase in vitro.
When the postsynaptic nicotinic receptors of rat adrenal medulla are activated transsynaptically the 3':5'-cyclic adenosine monophosphate (cAMP) content of chromaffin cells increases (1) (2) (3) (4) . The onset of the response is coupled to the stimulus but its duration is not (5) . We have reported that when the nicotinic receptors of adrenal medulla are stimulated by carbamylcholine the endogenous protein activator of cyclic 3':5'-nucleotide phosphodiesterase (PDE) (3':5'-cyclic-AMP 5'-nucleotidohydrolase, EC 3.1.4.17) increases in the soluble supernatant fraction (6) . The present report shows that the increase of cAMP elicited in adrenal medulla by cold exposure is also associated with an increase of the endogenous PDE activator (PDEA) in the cytosol. PDE, the only enzyme which hydrolyzes cAMP and 3': 5'-guanosine monophosphate (cGMP), exists in several molecular forms (7) (8) (9) (10) . The activity of a purified PDE that has only one Km (350 ,M) for cAMP and hydrolyzes cGMP (Km -5-9 MuM) (11, 12) can be regulated by PDEA. The activator lowers the Km of this PDE for cAMP and increases its Vmax for cGMP (12, 13) . The increase in cytosol PDEA activity which follows an increase in the cAMP content may be interpreted to indicate that cAMP triggers a compensatory mechanism that facilitates its own hydrolysis. To study the molecular nature of this regulation we have used as a model a membrane preparation from rat adrenal medulla or brain which contains bound PDEA. Preparation of Enzymes. Activator-deficient high-Km PDE was purified from rat brain by preparative polyacrylamide gel electrophoresis according to the method of Uzunov and Weiss (10) . This enzyme, when rechromatographed on analytical gel electrophoresis, yielded a single protein band. The endogenous protein activator of PDE was purified to homogeneity from bovine brain as described by Lin et al. (13) . This preparation showed only one protein band on analytical gel electrophoresis. Cyclic AMP-dependent protein kinase was prepared from bovine heart by the method of Kuo and Greengard (14) .
Preparation of the Membrane Fraction. The particulate fraction used for measuring bound PDEA was prepared by homogenizing the rat tissue in 4 volumes of 0.32 M sucrose containing either 25 mM or 150 mM KCl. The homogenate was centrifuged for 1 hr at 105,000 X g in a Beckman ultracentrifuge. The 105,000 X g pellet was washed several times with 0.32 M sucrose and rehomogenized in 5 ml of buffer containing 32 mM Tris-HCl, pH 7.5, 1 mM MgSO4, 20 ,tM CaCl2, and 0.6 mM dithiothreitol. The homogenate was then dialyzed against 200 volumes of the above buffer for 3 hr with two changes. For measurement of total bound PDEA, the pellet was rehomogenized in 2 ml of 1% Triton X-100.
Assay of PDE Activity. PDE activity was assayed by the isotopic method of Filburn and Karn (15 The relationship between the concentrations of cAMP and the activity of PDEA in the soluble supernatant of adrenal medullae of rats killed at various times after exposure to 40 is presented in Fig. 1 The adrenal glands were removed after decapitation and the medulla was separated from the cortex according to Guidotti and Costa (2) . PDEA was isolated from the homogenate using the procedure of Uzunov et al. (6) . PDEA activity in the cytosol was measured as described in Methods. The concentration of cAMP in the cytosol was measured by the method of Guidotti et al. (5 Distribution of PDEA in particulate and soluble fractions of rat brain and adrenal medulla. A rat brain (1.2 g) was homogenized in 0.32 M sucrose containing either 25 mM or 150 mM KCl and spun as described in Methods. The pellet was rinsed with 0.32 M sucrose and rehomogenized in 2 ml of 1% Triton X-100. Aliquots containing a wide range of protein concentrations from both the homogenized pellet and the soluble supernatant fraction were exposed to 95°for 3 min and centrifuged and PDEA activity in the supernatants was determined by the degree of activation of activator-deficient PDE as described in Methods. Adrenal medulla of rat was homogenized in 0.32 M sucrose containing 150 mM KCl and treated as described for rat brain. The PDEA activity in the soluble supernatant and Triton-solubilized particulate fraction was determined as described in Methods. The figures for PDEA activity represent a mean value of six experiments (L SEM). The phosphate acceptor that triggers the PDEA release could be either the PDEA itself or a membrane protein that binds PDEA. Not only was PDEA not an in vitro substrate for the protein kinase, but PDEA was a weak inhibitor of the cAMP-dependent and -independent phosphorylation of histones by protein kinase.
In order to see whether PDEA can be phosphorylated in vivo rats were injected intraventricularly with [y-32P]ATP (12.5 MCi per rat) and decapitated 4 hr later. The brains were homogenized in 0.32 M sucrose and the PDEA fraction was separated on preparative polyacrylamide gel electrophoresis. This fraction was then concentrated and subjected to analytical disk gel electrophoresis. One set of gels was stained while a duplicate was sliced and the radioactivity was counted. The band corresponding to that of purified PDEA did not contain 32p. This excludes the possibility that PDEA is a phosphate acceptor in the phosphorylation reaction that triggers its release from an enriched membrane preparation. (22) found that cAMP acts as a competitive inhibitor of ATP in protein phosphorylation. In the present report we also demonstrated that when the cAMP concentration is greater than 1 MM, the release of membrane bound PDEA by the protein kinase is reduced.
DISCUSSION ts (L SEM
In conclusion, we have shown that PDEA is present in a particulate cell fraction of brain homogenates and its release into the soluble fraction is facilitated by a cAMP-dependent protein kinase. The results from this study allow us to postulate the following mechanism to explain the regulation of cAMP content in postsynaptic cells of adrenal medulla following transsynaptic stimulation of adenylyl cyclase (Fig. 4) . This stimulus activates the membrane-bound adenylyl cyclase, and the intracellular content of cAMP is increased
